While not specifically approved for weight loss, many clients experience weight reduction as a secondary benefit
Wegovy, Mounjaro, Zepbound all weekly injections
Scientific References Polycystic ovary syndrome (PCOS prevalence 813%) The Lancet
Separately, Business Insider and Drug Discovery & Development published investigations documenting concerns about MEDVi-related advertising on Meta's platform, including ads running under apparent fictitious personas
If you have questions or concerns about your injections or treatment plan, speak with your healthcare provider.
Patients exploring options such as Mounjaro or Zepbound as part of a broader metabolic health conversation with their provider may find it helpful to compare how titration philosophies differ across compounds, since not every option follows the same dosing structure